Stock ALDX ALDEYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.93 USD -0.25% Intraday chart for Aldeyra Therapeutics, Inc. +1.81% +11.97%
Apr. 25 Transcript : Aldeyra Therapeutics, Inc. - Special Call
Apr. 04 North American Morning Briefing : Focus Turns to -2- DJ

Evolution of the average Target Price on Aldeyra Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e3e3de02.B76XmKqtdI-7vejANqM73iiSLi6q8dnsmM81MvD6jtY.KtjW_uGZFvX51cWlUvoIq2XXF2XZpKm09qtAapm09OZB2f3M6f0l7NXImw~c2107759a7539283216bf99f0a549b0b

Analyst Recommendations on Aldeyra Therapeutics, Inc.

Oppenheimer Upgrades Aldeyra Therapeutics to Outperform From Perform, $10 Price Target MT
Citigroup Adjusts Price Target on Aldeyra Therapeutics to $8 From $25, Maintains Buy Rating MT
Citigroup Adjusts Aldeyra Therapeutics Price Target to $25 From $28, Maintains Buy Rating MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors MT
Oppenheimer Adjusts Aldeyra Therapeutics Price Target to $11 From $10, Maintains Outperform Rating MT
Citigroup Adjusts Aldeyra Therapeutics' Price Target to $26 From $21, Reiterates Buy Rating MT
HC Wainwright Assumes Aldeyra Therapeutics at Buy with $15 Price Target MT
Berenberg Bank Adjusts Aldeyra Therapeutics PT to $28 From $32, Maintains Buy Rating MT
Alliance Global Partners Adjusts Aldeyra Therapeutics PT to $24 From $32, Maintains Buy Rating MT
Oppenheimer Adjusts Aldeyra Therapeutics' Price Target to $10 From $16, Maintains Outperform Rating MT
SVB Leerink Adjusts Aldeyra Therapeutics' Price Target to $15 From $24, Keeps Outperform Rating MT
Citigroup Adjusts Aldeyra Therapeutics' Price Target to $21 From $25, Keeps Buy Rating MT
Berenberg US CEO Conference FA
ALDEYRA THERAPEUTICS : SVB Leerink Starts Aldeyra Therapeutics at Outperform with $22 Price Target MT
ALDEYRA THERAPEUTICS : HC Wainwright Starts Aldeyra Therapeutics at Buy With $26 Price Target MT
ALDEYRA THERAPEUTICS : Berenberg Bank Initiates Coverage on Aldeyra Therapeutics With Buy Rating, $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
3.93 USD
Average target price
9.571 USD
Spread / Average Target
+143.55%
High Price Target
11 USD
Spread / Highest target
+179.90%
Low Price Target
7 USD
Spread / Lowest Target
+78.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aldeyra Therapeutics, Inc.

Oppenheimer
Citigroup
HC Wainwright
Berenberg Bank
SVB Leerink
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALDX Stock
  4. Consensus Aldeyra Therapeutics, Inc.